These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19368038)
41. [Adolescents who have tried illicit drugs and experienced psychiatric symptoms seldom seek professional help. A pilot study of 18-year old high school students in an urban district]. Gunnarsson M; Fahlke C; Balldin J Lakartidningen; 2004 Apr; 101(14):1280-2. PubMed ID: 15101214 [TBL] [Abstract][Full Text] [Related]
42. Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see pages 153-174). Sparenborg S; Vocci F; Zukin S Drug Alcohol Depend; 1997 Dec; 48(3):149-51. PubMed ID: 9449012 [No Abstract] [Full Text] [Related]
43. Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers. Vansickel AR; Fillmorex MT; Hays LR; Rush CR Am J Drug Alcohol Abuse; 2008; 34(3):293-305. PubMed ID: 18428072 [TBL] [Abstract][Full Text] [Related]
44. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Heidbreder CA; Hagan JJ Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634 [TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Brodie JD; Figueroa E; Laska EM; Dewey SL Synapse; 2005 Feb; 55(2):122-5. PubMed ID: 15543630 [TBL] [Abstract][Full Text] [Related]
46. Circumspectives: The Replacements. Heilig M; Carlezon WA Neuropsychopharmacology; 2015 Jul; 40(8):1813-4. PubMed ID: 26068571 [No Abstract] [Full Text] [Related]
47. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Kiluk BD; Carroll KM; Duhig A; Falk DE; Kampman K; Lai S; Litten RZ; McCann DJ; Montoya ID; Preston KL; Skolnick P; Weisner C; Woody G; Chandler R; Detke MJ; Dunn K; Dworkin RH; Fertig J; Gewandter J; Moeller FG; Ramey T; Ryan M; Silverman K; Strain EC Drug Alcohol Depend; 2016 Jan; 158():1-7. PubMed ID: 26652899 [TBL] [Abstract][Full Text] [Related]
48. Practice parameter for the use of stimulant medications. Ravenel SD J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1146-7; author reply 1147. PubMed ID: 12364835 [No Abstract] [Full Text] [Related]
50. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies. Fischer B; Blanken P; Da Silveira D; Gallassi A; Goldner EM; Rehm J; Tyndall M; Wood E Int J Drug Policy; 2015 Apr; 26(4):352-63. PubMed ID: 25662894 [TBL] [Abstract][Full Text] [Related]
51. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. Rothman RB; Blough BE; Baumann MH AAPS J; 2007 Jan; 9(1):E1-10. PubMed ID: 17408232 [TBL] [Abstract][Full Text] [Related]
52. Addiction to stimulants. Bell DS Med J Aust; 1967 Jan; 1(2):41-5. PubMed ID: 4381056 [No Abstract] [Full Text] [Related]
53. Speed, cocaine, and other psychostimulants death rates. Gold MS; Graham NA; Kobeissy FH; Pepine CJ; Goldberger BA Am J Cardiol; 2007 Oct; 100(7):1184. PubMed ID: 17884386 [No Abstract] [Full Text] [Related]
54. Behavioral therapies for drug abuse. Carroll KM; Onken LS Am J Psychiatry; 2005 Aug; 162(8):1452-60. PubMed ID: 16055766 [TBL] [Abstract][Full Text] [Related]
56. Ubiquitous Dopamine Deficit Hypotheses in Cocaine Use Disorder Lack Support. Leyton M Am J Psychiatry; 2021 May; 178(5):469. PubMed ID: 33979542 [No Abstract] [Full Text] [Related]
57. The combination of metyrapone and oxazepam for the treatment of cocaine and other drug addictions. Goeders NE; Guerin GF; Schmoutz CD Adv Pharmacol; 2014; 69():419-79. PubMed ID: 24484984 [TBL] [Abstract][Full Text] [Related]
58. Stimulant abuse treatment as HIV prevention. Shoptaw S; Reback CJ; Frosch DL; Rawson RA J Addict Dis; 1998; 17(4):19-32. PubMed ID: 9848029 [TBL] [Abstract][Full Text] [Related]